Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

IL4R and IL13 polymorphic variants and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to HBV vaccination or infection.

Grzegorzewska AE, Pajzderski D, Sowińska A, Mostowska A, Jagodziński PP.

Vaccine. 2013 Apr 3;31(14):1766-70. doi: 10.1016/j.vaccine.2013.02.023. Epub 2013 Feb 24.

PMID:
23462527
2.

Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection.

Grzegorzewska AE, Wobszal PM, Sowińska A, Mostowska A, Jagodziński PP.

Mol Biol Rep. 2013 Dec;40(12):6899-911. doi: 10.1007/s11033-013-2809-7. Epub 2013 Oct 25.

3.

The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.

Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B.

Vaccine. 2004 Sep 28;22(29-30):3963-7.

PMID:
15364445
4.

Interleukin-18 promoter polymorphism and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients.

Grzegorzewska AE, Wobszal P, Jagodziński PP.

Kidney Blood Press Res. 2012;35(1):1-8. doi: 10.1159/000329932. Epub 2011 Aug 10.

6.

Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients.

Lin SY, Liu JH, Lin CC, Wang SM, Tsai CA, Chou CY, Kuo HL, Wang IK, Liu YL, Lin HH, Huang CC.

Vaccine. 2011 May 12;29(21):3738-41. doi: 10.1016/j.vaccine.2011.03.049. Epub 2011 Mar 31.

PMID:
21458609
7.

Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients.

Grzegorzewska AE, Wobszal PM, Mostowska A, Jagodziński PP.

BMC Nephrol. 2012 Aug 3;13:75. doi: 10.1186/1471-2369-13-75.

8.

Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination.

Lindemann M, Barsegian V, Siffert W, Ferencik S, Roggendorf M, Grosse-Wilde H.

Virology. 2002 Jun 5;297(2):245-52.

9.

Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.

Tsouchnikas I, Dounousi E, Xanthopoulou K, Papakonstantinou S, Thomoglou V, Tsakiris D.

Clin Nephrol. 2007 Oct;68(4):228-34.

PMID:
17969490
10.
11.

Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection.

Böcher WO, Herzog-Hauff S, Herr W, Heermann K, Gerken G, Meyer Zum Büschenfelde KH, Löhr HF.

Clin Exp Immunol. 1996 Jul;105(1):52-8.

12.

Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.

Boot HJ, Hahné S, Cremer J, Wong A, Boland G, van Loon AM.

J Viral Hepat. 2010 Dec;17(12):872-8. doi: 10.1111/j.1365-2893.2009.01247.x.

PMID:
20051008
14.

Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.

Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.

Vaccine. 2012 Jun 8;30(27):4034-9. doi: 10.1016/j.vaccine.2012.04.031. Epub 2012 Apr 22.

PMID:
22531558
15.
16.

Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.

Halota W, Muszyńska M, Pawłowska M.

Med Sci Monit. 2002 Jul;8(7):CR516-9.

17.

Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates.

Junqueira AL, Tavares VR, Martins RM, Frauzino KV, Silva AM, Rodrigues IM, Minamisava R, Teles SA.

Mem Inst Oswaldo Cruz. 2011 Feb;106(1):113-6.

18.

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS.

Ann Intern Med. 2005 Mar 1;142(5):333-41.

PMID:
15738452
19.

High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.

Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):203-8. doi: 10.1097/MPG.0b013e3181819ad4.

PMID:
19179883
20.

A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.

Liu YL, Kao MT, Huang CC.

Vaccine. 2005 Jun 10;23(30):3957-60. Epub 2005 Mar 27.

PMID:
15917117

Supplemental Content

Support Center